Thursday, December 29, 2016 11:16:36 AM
NanoViricides, Inc.
NLS Time (ET)NLS PriceNLS Share Volume
10:43:09 $ 1.0599 1,500
10:27:45 $ 1.06 600
10:27:36 $ 1.05 600
10:27:09 $ 1.05 7,564
10:27:09 $ 1.045 300
10:27:09 $ 1.05 4,600
10:27:06 $ 1.045 100
10:27:06 $ 1.045 100,000
10:25:51 $ 1.05 200
10:25:51 $ 1.045 100
10:25:45 $ 1.05 1,300
10:25:45 $ 1.045 100
10:25:40 $ 1.045 5,200
10:25:40 $ 1.0448 1,800
10:20:32 $ 1.0401 100
10:08:38 $ 1.045 100
10:04:40 $ 1.045 100
10:04:27 $ 1.045 100
09:59:29 $ 1.05 200
09:59:23 $ 1.05 100
09:58:28 $ 1.0501 200
09:54:36 $ 1.08 100
09:51:16 $ 1.0627 1,000
09:49:27 $ 1.06 200
09:49:27 $ 1.06 1,000
09:47:14 $ 1.06 500
09:46:40 $ 1.06 100
09:46:40 $ 1.0601 5,000
09:46:13 $ 1.06 100
09:46:12 $ 1.0649 5,800
Read more: nasdaq.com
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM